Position in VTRS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,064,415
+$239,945 QoQ
Shares Held
130,001
-3.7% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#250
of 1,016 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Baird Financial Group, Inc. holds $29,735,464 across 12 Drug Manufacturers - Specialty & Generic names. VTRS ranks #6 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
131,829 | $9,473,231 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
39,868 | $6,719,350 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
29,356 | $3,256,753 | |
| 4 | ALKS |
Alkermes plc.
|
53,267 | $2,791,190 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
65,575 | $2,273,484 | |
| 6 | VTRS |
Viatris Inc
This page
|
130,001 | $2,064,415 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
30,708 | $1,963,776 | |
| 8 | PAHC |
Phibro Animal Health Corp
|
10,710 | $336,293 |
All Filings in VTRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,064,415 | 130,001 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,824,470 | 135,046 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $136,014 | 10,925 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $103,346 | 10,439 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $96,613 | 10,819 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $127,853 | 14,679 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $5,200,488 | 417,710 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,776,412 | 411,405 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,843,879 | 173,460 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $163,935 | 13,730 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $227,982 | 21,051 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $354,790 | 35,983 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $345,894 | 34,659 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $382,711 | 39,783 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $465,366 | 41,812 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $441,105 | 51,773 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $1,141,281 | 109,005 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $1,364,721 | 125,434 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,864,379 | 137,796 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $2,727,491 | 201,291 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $2,838,236 | 198,617 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $2,692,465 | 192,732 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $9,761,627 | 520,898 | Shares | Defined | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||